About Yutaka Iijima

This author has not yet filled in any details.
So far Yutaka Iijima has created 2 blog entries.

VLP Therapeutics names seasoned biotech venture capitalist Miwa Toyoda as CBO

2021-03-14T11:28:14-04:002021.03.15|

Gaithersburg, MD — US-based biotech company VLP Therapeutics, Inc. (VLPT) announced that it has named Ms. Miwa Toyoda, formerly a venture capitalist specialized in pharma and biotech at JAFCO Group Co., Ltd., as chief business officer, effective March 15, in a bid to accelerate its vaccine research and development projects and expand the portfolio. From

VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D

2021-03-25T21:15:43-04:002021.03.15|

Gaithersburg, MD — US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on March 15 that it has raised US$16 million in a Series A funding round from MIYAKO Capital Co., Ltd., Sojitz Corporation, Konishiyasu Co., Ltd. in Japan, and three existing investors in the US (Mr. Robert G. Hisaoka, SK Impact Fund, LLC, and RJ